Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

EMA's Restriction Of Multaq Indication Could Spell Death Knell For The Drug In Europe

Sep 23 2011

• By The Pink Sheet Daily

Related Content

EU Advisory Panel Clears Sanofi’s Jevtana But Wants to Review Multaq’s Liver Risks

Jan 21 2011

Where A REMS Didn't Help: Sanofi Must Deal With Liver Injuries With Multaq

Jan 14 2011

Sanofi Halts Multaq Trial Early Due To Cardiac Events

Jul 07 2011

Additional Topics

Europe BioPharmaceutical

More from Europe

More from Geography

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window